KonstantinosPapadakisMDPhD

Gastroenterology • Rochester, MN

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Professor of Medicine, Mayo Medical School

Join to view full profile

Dr. Papadakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Papadakis' full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-266-0873

Fax+1 507-293-3917

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1997 - 2000
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1994 - 1997
University of Crete School of Health SciencesClass of 1993

Certifications & Licensure

CA State Medical License 1997 - 2026
MN State Medical License 2012 - 2025
American Board of Internal Medicine Gastroenterology

Clinical Trials

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) Start of enrollment: 2021 Sep 13
Recruiting
Phase 2
Roles: Contact
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet Start of enrollment: 2022 Jun 30
Active, not recruiting
Phase 2
Roles: Principal Investigator

Publications & Presentations

PubMed

25 citations
Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge.
Joseph A Murray, Jack A Syage, Tsung-Teh Wu, Matthew A Dickason, Ana G Ramos
Gastroenterology. 2022-12-01
2 citations
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience.
Guilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, Adam C Bledsoe, Kevin P Quinn
Crohn's & Colitis 360. 2021-07-01
39 citations
Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
Badr Al-Bawardy, Guilherme Piovezani Ramos, Maria Alice V. Willrich, Sarah M. Jenkins, Sang Hyoung Park
Inflammatory Bowel Diseases. 2019-02-21